Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histamine release via IgE-mediated mast cell activation is a critical effector mechanism in type I hypersensitivity reactions. It involves allergen-driven cross-linking of surface-bound IgE on FcεRI-expressing mast cells leading to rapid degranulation with subsequent local or systemic inflammatory effects that underpin many allergic disorders. Regulation occurs at multiple levels including receptor expression modulated by cytokines and circulating antibody concentration. This pathway remains a major target for anti-allergy drug development due to its central role in disease pathogenesis.
N/A
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histamine Release via IgE-Mediated Mast Cell Activation (N/A).